Hyogo, Japan

Miyuki Horiuchi

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Miyuki Horiuchi. Retrieved from https://idiyas.com/inventor/miyuki-horiuchi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 14.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Miyuki Horiuchi

Introduction:

Miyuki Horiuchi, a talented inventor based in Hyogo, Japan, has made significant contributions to the field of pharmaceuticals with his innovative work. With a focus on dipeptide nitriles, he has demonstrated a keen understanding of complex chemical compounds.

Latest Patents:

Miyuki Horiuchi currently holds 1 patent for his work on dipeptide nitriles. This patent showcases his expertise in developing novel compounds that have the potential to revolutionize the pharmaceutical industry.

Career Highlights:

Miyuki Horiuchi is a key member of the research team at Novartis AG, a global pharmaceutical company known for its cutting-edge innovations. His dedication to advancing medical science has earned him recognition within the industry.

Collaborations:

In his pursuit of excellence, Miyuki Horiuchi has collaborated with esteemed colleagues such as Eva Altmann and Claudia Betschart. Together, they have explored new possibilities in drug development and brought fresh perspectives to their research.

Conclusion:

Miyuki Horiuchi's passion for innovation and his commitment to pushing the boundaries of pharmaceutical science make him a standout inventor in his field. His groundbreaking work on dipeptide nitriles serves as a testament to his creativity and ingenuity in the world of patents and inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…